MRI of the prostate without endorectal coil: A new French exception?;L'IRM de la prostate sans antenne endorectale : une nouvelle exception française?

Journal de Radiologie

Volumn 89, Issue 2, 2008, Pages 191-192

  Cornud, F ^a   Dana, A ^b   Portalez, D ^c  

^a Institut Cochin   (France)

^b Institut de Radiologie   (France)

^c CLINIQUE PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFACT; COMPARATIVE STUDY; EDITORIAL; FUNCTIONAL MAGNETIC RESONANCE IMAGING; MEDICAL RESEARCH; NUCLEAR MAGNETIC RESONANCE IMAGING; PROSTATE; RADIODIAGNOSIS; RELIABILITY; SENSITIVITY AND SPECIFICITY; SPECTROSCOPY;

EID: 44049103808     PISSN: 02210363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0221-0363(08)70393-7     Document Type: Editorial

References (18)

1. Hricak H, White S, VigneronD, Kurhanewicz J, Kosco A, Levin D et al. Carcinoma ofthe prostate gland: MR imaging with pelvic phased-array coils versusintegrated endorectal--pelvic phased-array coils. Radiology 1994;193(3):703-9.
2. Yu KK, Hricak H, AlagappanR, Chernoff DM, Bacchetti P, Zaloudek CJ. Detection of extracapsularextension of prostate carcinoma with endorectal and phased-arraycoil MR imaging: multivariate feature analysis. Radiology 1997;202(3):697-702.
3. Cornud F, Flam T, ChauveincL, Hamida K, Chretien Y, Vieillefond A et al. Extraprostatic spreadof clinically localized prostate cancer: factors predictive of pT3tumor and of positive endorectal MR imaging examination results.Radiology 2002;224(1):203-10.
4. Engelbrecht MR, Jager GJ,Laheij RJ, Verbeek AL, Van Lier HJ, Barentsz JO. Local staging ofprostate cancer using magnetic resonance imaging: a meta-analysis.Eur Radiol 2002;12(9):2294-302.
5. Futterer JJ, Engelbrecht MR,Jager GJ, Hartman RP, King BF, Hulsbergen-Van de Kaa CA et al. Prostatecancer: comparison of local staging accuracy of pelvic phased-arraycoil alone versus integrated endorectal-pelvic phased-array coils.Local staging accuracy of prostate cancer using endorectal coilMR imaging. Eur Radiol 2007;17(4):1055-65.
6. Heijmink SW, Futterer JJ,Hambrock T, Takahashi S, Scheenen TW, Huisman HJ et al.Prostate Cancer: Body-Array versus Endorectal Coil MR Imaging at3 T--Comparison of Image Quality, Localization, and Staging Performance.Radiology 2007;244(1):184-95.
7. Huisman HJ, Futterer JJ, vanLin ENJT, Welmers A, Scheenen TWJ, van Dalen JA et al. ProstateCancer: Precision of Integrating Functional MR Imaging with RadiationTherapy Treatment by Using Fiducial Gold Markers. Radiology 2005;236(1):311-17.
8. Villers A, Puech P, MoutonD, Leroy X, Ballereau C, Lemaitre L. Dynamic contrast enhanced,pelvic phased array magnetic resonance imaging of localized prostatecancer for predicting tumor volume: correlation with radical prostatectomyfindings. J Urol 2006;176(6 Pt 1):2432-7.
9. Girouin N, Mege-LechevallierF, Tonina Senes A, Bissery A, Rabilloud M, Marechal JM et al. Prostatedynamic contrast-enhanced MRI with simple visual diagnostic criteria:is it reasonable? Eur Radiol 2007;17(6):1498-509.
10. Zakian KL, Sircar K, HricakH, Chen H-N, Shukla-Dave A, Eberhardt S et al. Correlation of ProtonMR Spectroscopic Imaging with Gleason Score Based on Step-SectionPathologic Analysis after Radical Prostatectomy. Radiology 2005;234(3):804-14.
11. Shukla-Dave A, Hricak H,Eberhardt SC, Olgac S, Muruganandham M, Scardino PT et al. ChronicProstatitis: MR Imaging and 1H MR Spectroscopic Imaging Findings--InitialObservations. Radiology 2004;231(3):717-24.
12. Zakian KL, Eberhardt S, HricakH, Shukla-Dave A, Kleinman S, Muruganandham M et al. TransitionZone Prostate Cancer: Metabolic Characteristics at H MR SpectroscopicImaging--Initial Results. Radiology 2003;229(1):241-47.
13. Choi YJ, Kim JK, Kim N, KimKW, Choi EK, Cho KS. Functional MR imaging of prostate cancer. Radiographics2007;27(1):63-75; discussion 75-7.
14. Ocak I, Bernardo M, MetzgerG, Barrett T, Pinto P, Albert PS et al. Dynamic Contrast-EnhancedMRI of Prostate Cancer at 3 T: A Study of PharmacokineticParameters. 10.2214/AJR.06.1329. Am J Roentgenol 2007;189(4):W192-201.
15. Futterer JJ, Heijmink SW,Scheenen TW, Veltman J, Huisman HJ, Vos P et al. Prostate cancerlocalization with dynamic contrast-enhanced MR imaging and protonMR spectroscopic imaging. Radiology 2006;241(2):449-58.
16. Reinsberg SA, Payne GS, RichesSF, Ashley S, Brewster JM, Mce:affiliationan VA et al. Combined Use of Diffusion-WeightedMRI and 1H MR Spectroscopy to Increase Accuracy in Prostate CancerDetection. Am J Roentgenol 2007;188(1):91-8.
17. Tanimoto A, Nakashima J,Kohno H, Shinmoto H, Kuribayashi S. Prostate cancer screening: theclinical value of diffusion-weighted imaging and dynamic MR imagingin combination with T2-weighted imaging. J Magn Reson Imaging 2007;25(1):146-52.
18. Shukla-Dave A, Hricak H,Kattan MW, Pucar D, Kuroiwa K, Chen HN et al. The utility of magneticresonance imaging and spectroscopy for predicting insignificantprostate cancer: an initial analysis. BJU Int 2007;99(4):786-93.